Durvalumab
listen (dur-VAL-yoo-mab)
This page contains brief information about durvalumab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Imfinzi
FDA Approved
Yes
Use in Cancer
Durvalumab is approved to treat:
- Urothelial carcinoma (a type of bladder cancer) that is locally advanced or has metastasized (spread to other parts of the body). It is used in patients whose disease got worse during or after treatment with platinum chemotherapy.
Durvalumab is also being studied in the treatment of other types of cancer.
More About Durvalumab
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
FDA Approves Three Immunotherapy Drugs for Patients with Bladder Cancer
Clinical Trials Accepting Patients
Find Clinical Trials for Durvalumab - Check for trials from NCI's list of cancer clinical trials now accepting patients.